Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last €139.76 EUR
Change Today -4.37 / -3.03%
Volume 10.7K
As of 3:46 PM 04/30/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Jonathan M. Peacock

Former Chief Financial Officer, Amgen Inc.
AgeTotal Calculated CompensationThis person is connected to 21 board members in 3 different organizations across 4 different industries.

See Board Relationships
56$4,954,723
As of Fiscal Year 2014

Background*

Mr. Jonathan M. Peacock, also known as Jon, has been the Chairman, President and Chief Executive Officer of Bellerophon Therapeutics LLC since June 2014. Mr. Peacock has been the Chief Financial Officer and Executive Vice President of Micromet Inc. since March 2012. Mr. Peacock served as the Chief Financial Officer and Executive Vice President at Amgen Inc. from September 1, 2010 to January 10, 2014. He was responsible for Amgen's finance and investor relations operations. ...

Read Full Background

Corporate Headquarters*

One Amgen Center Drive
Thousand Oaks, California 91320

United States

Phone: 805-447-1000
Fax: 805-447-1010

Board Members Memberships*

2012-Present
Chief Financial Officer, Executive Vice President and Director
2014-Present
Independent Director and Chairman of Audit Committee
2014-Present
Chairman, Chief Executive Officer and President

Education*

MA
The University of St Andrews

Other Affiliations*

Annual Compensation*

Salary$201,539
Bonus$224,000
Total Annual Compensation$425,539

Stock Options*

All Other Compensation$58,351
Exercisable Options90,082
Unexercisable Options360,329
Total Number of Options450,411

Total Compensation*

Total Annual Cash Compensation$483,890
Total Short Term Compensation$425,539
Other Long Term Compensation$58,351
Total Calculated Compensation$4,954,723
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
AMG:GR €139.76 EUR -4.37

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact AMGEN INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.